| scholarly article | Q13442814 |
| P50 | author | Roman Zubarev | Q57638345 |
| P2093 | author name string | Pratima Sinha | |
| Suzanne Ostrand-Rosenberg | |||
| Konstantin A Artemenko | |||
| Olesya Chornoguz | |||
| Lydia Grmai | |||
| P2860 | cites work | Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor | Q41902311 |
| Aberrant integrin activation induces p38 MAPK phosphorylation resulting in suppressed Fas-mediated apoptosis in T cells: implications for rheumatoid arthritis | Q43287966 | ||
| Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo | Q43687301 | ||
| CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress | Q46925832 | ||
| A novel orthotopic model of breast cancer metastasis to bone. | Q52826484 | ||
| Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. | Q54142377 | ||
| Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells | Q80274418 | ||
| Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response | Q80582229 | ||
| CD11b+/Gr-1+ immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1beta-secreting cells | Q81598364 | ||
| Inhibition of death receptor signals by cellular FLIP | Q24316446 | ||
| Myeloid-derived suppressor cells: linking inflammation and cancer | Q24641811 | ||
| Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein | Q24641894 | ||
| Inflammation and cancer | Q24649640 | ||
| Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
| Probability-based protein identification by searching sequence databases using mass spectrometry data | Q27860736 | ||
| Inflammation and cancer: back to Virchow? | Q28036756 | ||
| Myeloid-derived suppressor cells as regulators of the immune system | Q28131637 | ||
| The biochemistry of apoptosis | Q29547741 | ||
| Identification of dominant signaling pathways from proteomics expression data. | Q31158597 | ||
| TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses | Q34089674 | ||
| Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23. | Q34300816 | ||
| Chronic inflammation and cancer | Q34544187 | ||
| Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression | Q35478848 | ||
| IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function. | Q36026855 | ||
| Breast cancer immunotherapy | Q36286468 | ||
| Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence. | Q36371536 | ||
| p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils | Q36399260 | ||
| Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma | Q36403544 | ||
| Polarized immune responses differentially regulate cancer development | Q36808629 | ||
| Less yin, more yang: confronting the barriers to cancer immunotherapy | Q36944375 | ||
| Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity | Q36996588 | ||
| Immune surveillance: a balance between protumor and antitumor immunity | Q37097545 | ||
| Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4 | Q37232937 | ||
| Analysis of the Salmonella typhimurium proteome through environmental response toward infectious conditions | Q40282069 | ||
| Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression | Q40338318 | ||
| TGF-beta inhibits Fas-mediated apoptosis of a follicular dendritic cell line by down-regulating the expression of Fas and caspase-8: counteracting role of TGF-beta on TNF sensitization of Fas-mediated apoptosis | Q40425571 | ||
| Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. | Q40474320 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P921 | main subject | apoptotic process | Q14599311 |
| inflammation | Q101991 | ||
| pathway analysis | Q25303877 | ||
| P304 | page(s) | M110.002980 | |
| P577 | publication date | 2010-12-29 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis | |
| P478 | volume | 10 |
| Q36413721 | A core of kinase-regulated interactomes defines the neoplastic MDSC lineage |
| Q92299091 | AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging |
| Q34940395 | CD11b+GR1+ myeloid cells secrete NGF and promote trigeminal ganglion neurite growth: implications for corneal nerve regeneration. |
| Q47400753 | Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive Functions. |
| Q38592376 | Drafting the proteome landscape of myeloid-derived suppressor cells. |
| Q28386923 | ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis |
| Q35955347 | Expansion of myeloid-derived suppressor cells with arginase activity lasts longer in aged than in young mice after CpG-ODN plus IFA treatment |
| Q45344986 | Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer |
| Q42360945 | High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy |
| Q38141522 | History of myeloid-derived suppressor cells |
| Q37706260 | IL-17A weakens the antitumor immuity by inhibiting apoptosis of MDSCs in Lewis lung carcinoma bearing mice |
| Q36767546 | Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2. |
| Q40385399 | Myeloid-Derived Suppressor Cells |
| Q26799126 | Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment |
| Q48293607 | Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment |
| Q38223250 | Myeloid-derived suppressor cell heterogeneity in human cancers |
| Q28084627 | Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected |
| Q41952605 | Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves |
| Q37863217 | Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy |
| Q36896764 | Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer |
| Q40217401 | Neonatal myeloid derived suppressor cells show reduced apoptosis and immunosuppressive activity upon infection with Escherichia coli. |
| Q50220559 | Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model |
| Q42493330 | Peptide-based systems analysis of inflammation induced myeloid-derived suppressor cells reveals diverse signaling pathways |
| Q37689678 | Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers |
| Q33723734 | Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy |
| Q41556414 | Role of exosomal proteins in cancer diagnosis |
| Q46064256 | Surface Glycoproteins of Exosomes Shed by Myeloid-Derived Suppressor Cells Contribute to Function |
| Q30361738 | The functions and clinical applications of tumor-derived exosomes |
| Q41379079 | Tolerance and immune suppression in the tumor microenvironment |
| Q40064673 | Top-down analysis of low mass proteins in exosomes shed by murine myeloid-derived suppressor cells |
| Q38067642 | Tumor microenvironment and myeloid-derived suppressor cells |
| Q97644531 | Upregulated TRAIL and Reduced DcR2 Mediate Apoptosis of Decidual PMN-MDSC in Unexplained Recurrent Pregnancy Loss |
| Q35067364 | Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography |
Search more.